ARTICLE
A short technical note on cagrilintide as a reference standard
A short note summarizing the receptor-binding profile of cagrilintide in cell-based assays, for researchers selecting reference standards for in-vitro amylin-receptor work.
— Coastal Vanguard LLC
Cagrilintide is a synthetic peptide reference standard in the amylin-analogue class. This note summarizes the in-vitro evidence and is provided for laboratory researchers.
**Receptor binding.** The reference lyophilize has been characterized in cell-based receptor binding assays at the amylin-receptor subtypes (AMY1, AMY2, AMY3) and at the calcitonin receptor. The published in-vitro work shows a binding profile distinct from the endogenous ligand amylin and supports the use of cagrilintide as a reference standard in amylin-receptor pharmacology.
**Use as a reference standard.** Researchers selecting cagrilintide for in-vitro amylin-receptor work should consult the lot-specific Certificate of Analysis for the documented HPLC purity, mass-spectrometry identity, and endotoxin levels. The catalog provides the reference standard in a 10 mg lyophilized single-vial unit.
**Selection of lot.** Each lot is documented and traceable. Researchers requiring matched lots for parallel protocols can request lot-reserved ordering from the research desk.
**All references cited in this note refer to in-vitro, ex-vivo, and preclinical animal-model work. No reference in this note should be read as evidence of human or veterinary applicability of any catalog product.**